Oregon HSU

Portland, Oregon 97239

0 studies enrolling now · 4 studies all time

What they study most

Cardiotoxicity, Diabetic Macular Edema, Neovascular Age-Related Macular Degeneration, Non-Small Cell Lung Cancer, Uveitic Macular Edema

Studies at this site

• Extension Study for the Port Delivery System With Ranibizumab (Portal) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema — Completed
• Vascular Cardiotoxicity of Ponatinib — Status unconfirmed